Literature DB >> 26088816

HLA class II susceptibility pattern for type 1 diabetes (T1D) in an Iranian population.

J Kiani1, M Hajilooi2, D Furst3, H Rezaei3, S Shahryari-Hesami3, S Kowsarifard1, A Zamani3, G Solgi3,4.   

Abstract

This study aimed to determine the HLA-DRB1/HLA-DQB1 susceptibility and protection pattern for type 1 diabetes (T1D) in a population from Hamadan, north-west of Iran. A total of 133 patients with T1D were tested for HLA-DRB1 and HLA-DQB1 alleles using PCR-SSP compared to 100 ethnic-matched healthy controls. Alleles and haplotypes frequencies were compared between both groups. The most susceptible alleles for disease were HLA-DRB1*03:01, DRB1*04:02, DQB1*02:01 and DQB1*03:02, and protective alleles were HLA-DRB1*07:01, *11:01, *13:01, *14:01 and DRB1*15 and HLA-DQB1*06:01, *06:02 and *06:03. Haplotype analysis revealed that patients with T1D had higher frequencies of DRB1*03:01-DQB1*02:01 (OR = 4.86, P < 10(-7) ) and DRB1*04:02-DQB1*03:02 (OR = 9.93, P < 10(-7) ) and lower frequencies of DRB1*07:01-DQB1*02:01 (P = 0.0005), DRB1*11:01-DQB1*03:01 (P = 0.001), DRB1*13:01-DQB1*06:03 (P = 0.002) and DRB1*15-DQB1*06:01 (P = 0.001) haplotypes compared to healthy controls. Heterozygote combination of both susceptible haplotypes (DR3/DR4) confers the highest risk for T1D (RR = 18.80, P = 4 × 10(-5) ). Additionally, patients with homozygote diplotype, DR3/DR3 and DR4/DR4, showed a similar risk with less extent to heterozygote combination (P = 0.0004 and P = 0.01, respectively). Our findings not only confirm earlier reports from Iranians but also are in line with Caucasians and partly with Asians and some African patients with T1D. Remarkable differences were the identification of DRB1*04:01-DQB1*03:02, DRB1*07:01-DQB1*03:03 and DRB1*16-DQB1*05:02 as neutral and DRB1*13:01-DQB1*06:03 as the most protective haplotypes in this study.
© 2015 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26088816     DOI: 10.1111/iji.12216

Source DB:  PubMed          Journal:  Int J Immunogenet        ISSN: 1744-3121            Impact factor:   1.466


  2 in total

1.  HLA class II alleles and risk for peripheral neuropathy in type 2 diabetes patients.

Authors:  Ahmad Marzban; Javad Kiani; Mehrdad Hajilooi; Hamzeh Rezaei; Zohreh Kahramfar; Ghasem Solgi
Journal:  Neural Regen Res       Date:  2016-11       Impact factor: 5.135

2.  HLA Genotypes and Type 1 Diabetes and Its Relationship to Reported Race/Skin Color in Their Relatives: A Brazilian Multicenter Study.

Authors:  Marília B Gomes; Luís C Porto; Dayse A Silva; Carlos A Negrato; Elizabeth João Pavin; Renan Montenegro Junior; Sergio A Dib; João S Felício; Deborah C Santos; Luiza H Muniz; Rosângela Réa; Rossana Sousa Azulay; Vandilson Rodrigues
Journal:  Genes (Basel)       Date:  2022-05-29       Impact factor: 4.141

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.